Jasper Therapeutics
JSPR
JSPR
25 hedge funds and large institutions have $161M invested in Jasper Therapeutics in 2021 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
57% more capital invested
Capital invested by funds: $102M → $161M (+$58.4M)
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
5.72% more ownership
Funds ownership: 0% → 5.72% (+5.7%)
Holders
25
Holding in Top 10
3
Calls
$2.02M
Puts
$274K
Top Buyers
| 1 | +$4.24M | |
| 2 | +$3.79M | |
| 3 | +$1.71M | |
| 4 |
Morgan Stanley
New York
|
+$1.49M |
| 5 |
BlackRock
New York
|
+$1.33M |
Top Sellers
| 1 | -$2.3M | |
| 2 | -$815K | |
| 3 | -$267K | |
| 4 |
Tudor Investment Corp
Stamford,
Connecticut
|
-$205K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$47.7K |